Search & Analyze
Popular Searches
SMS Pharmaceuticals Ltd.
Healthcare₹386.600.77%
24 Jul, 4:01 PM
CMP₹386.60
Mkt Cap₹3.61K Cr
P/E35.35
P/B4.59
ROE11.91%
52W High₹446.50
52W Low₹208.20
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
35.35
P/B Ratio
4.59
EV/EBITDA
21.85
Price/Sales
4.07
Dividend Yield (%)
0.10
EPS (TTM ₹)
10.89
Book Value (₹)
83.91
ROE (%)
11.91
ROCE (%)
12.55
ROA (%)
6.07
EBITDA Margin (%)
16.42
Net Profit Margin (%)
7.96
Debt/Equity
0.50
Current Ratio
1.67
Interest Coverage
5.98
Asset Turnover
0.76
Working Capital/Sales
3.68
Core EBITDA Growth (%)
19.80
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 56317.75 | 51987.43 | 52205.14 | 70926.34 | 78274.81 |
| Net Sales | 56317.75 | 51987.43 | 52205.14 | 70926.34 | 78274.81 |
| Total Income | 56663.04 | 52507.2 | 52696.52 | 71372.31 | 78897.25 |
| Total Expenditure | 44204.04 | 40525.65 | 46751.65 | 59250.49 | 64375.68 |
| Operating Profit | 12459 | 11981.55 | 5944.87 | 12121.82 | 14521.57 |
| Depreciation | 2228.16 | 3215.25 | 3212.54 | 3151.57 | 3433.73 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 9111.98 | 6849.91 | 534.91 | 6610.68 | 9233.75 |
| Tax | 3015.52 | 61.82 | 146.5 | 1690.68 | 2493.93 |
| Profit After Tax (PAT) | 6096.46 | 6788.09 | 388.41 | 4920 | 6739.82 |
| EPS (₹) | 7.39 | 7.35 | -0.83 | 5.89 | 8.16 |
| Dividend Payout % | 30 | 30 | 30 | 40 | 40 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 846.52 | 846.52 | 846.52 | 846.52 | 886.52 |
| Reserves | 40206.29 | 46182.34 | 45206 | 49928.87 | 61490.41 |
| Shareholders Funds | 41052.81 | 47028.86 | 46052.52 | 53632.89 | 63964.43 |
| Total Debt | 25051.53 | 26011.37 | 25251.34 | 28017.87 | 31075.57 |
| Total Liabilities | 82821.29 | 87450.17 | 87966.51 | 104909.26 | 117281.47 |
| Total Assets | 82821.29 | 87450.17 | 87966.51 | 104909.26 | 117281.47 |
| Book Value / Share | 48.496 | 55.5555 | 54.4022 | 59.9813 | 70.3616 |
| Assets | 82821.29 | 87450.17 | 87966.51 | 104909.26 | 117281.47 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 9045.34 | 4505.97 | 2245 | 5012.47 | 8170.93 |
| Investing Activities | -15159.23 | -2715.3 | -2975.61 | -5207.2 | -12342.89 |
| Financing Activities | 9201.78 | -1174.7 | -3196.89 | 3067.9 | 4707.92 |
| Net Cash Flow | 3087.89 | 615.97 | -3927.5 | 2873.17 | 535.96 |
SMSPHARMA
₹386.60
+0.77%